Combining health technology assessment and health technology management to deliver cost-effective prescribing and cost containment – the Irish experience-Reference-Cited by-同舟云学术

Combining health technology assessment and health technology management to deliver cost-effective prescribing and cost containment – the Irish experience

Published:2020-09-02 Issue:5 Volume:20 Page:431-436
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Smith Amelia¹²^ORCID,Barry Michael¹²

Affiliation:

1. Department of Pharmacology and Therapeutics, Trinity College Dublin, Trinity Centre for Health Sciences, St. James’ Hospital, Dublin 8, Ireland

2. Medicines Management Programme, Health Service Executive, St. James’ Hospital, Dublin 8, Ireland

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2020.1822739

Reference17 articles.

1. HTA Around the World: Broadening Our Understanding of Cross-Country Differences

2. Do Social Values and Institutional Context Shape the Use of Economic Evaluation in Reimbursement Decisions? An Empirical Analysis

3. Differences in Health Technology Assessment Recommendations Among European Jurisdictions: The Role of Practice Variations

4. The Pharmacoeconomic Evaluation Process in Ireland

5. Prescribing and the core curriculum for tomorrow's doctors: BPS curriculum in clinical pharmacology and prescribing for medical students

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilising Health Technology Assessment to Develop Managed Access Protocols to Facilitate Drug Reimbursement in Ireland;Applied Health Economics and Health Policy;2024-08-12

2. Utilization, Expenditure, and Treatment Patterns Associated With Calcitonin Gene-Related Peptide Monoclonal Antibodies Reimbursed Subject to a Managed Access Protocol in Ireland;Value in Health;2024-08

3. Health technology management: the experience of a managed access approach to the reimbursement of dupilumab in Ireland;Irish Journal of Medical Science (1971 -);2023-05-09

4. Utilisation and expenditure on glucose-lowering drugs used for the treatment of type 2 diabetes mellitus in Ireland, a repeated cross-sectional study;Diabetes Epidemiology and Management;2022-01